GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » International Stem Cell Corp (OTCPK:ISCO) » Definitions » Cyclically Adjusted Book per Share

ISCO (International Stem Cell) Cyclically Adjusted Book per Share : $-0.31 (As of Dec. 2024)


View and export this data going back to 2006. Start your Free Trial

What is International Stem Cell Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

International Stem Cell's adjusted book value per share for the three months ended in Dec. 2024 was $-0.492. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $-0.31 for the trailing ten years ended in Dec. 2024.

During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 7.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of International Stem Cell was 7.40% per year. The lowest was -24.30% per year. And the median was -15.55% per year.

As of today (2025-05-15), International Stem Cell's current stock price is $0.11. International Stem Cell's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2024 was $-0.31. International Stem Cell's Cyclically Adjusted PB Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PB Ratio of International Stem Cell was 5.29. The lowest was 0.20. And the median was 0.85.


International Stem Cell Cyclically Adjusted Book per Share Historical Data

The historical data trend for International Stem Cell's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

International Stem Cell Cyclically Adjusted Book per Share Chart

International Stem Cell Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.78 -0.39 -0.68 -0.41 -0.31

International Stem Cell Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.41 -0.29 -0.30 -0.29 -0.31

Competitive Comparison of International Stem Cell's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, International Stem Cell's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


International Stem Cell's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, International Stem Cell's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where International Stem Cell's Cyclically Adjusted PB Ratio falls into.


;
;

International Stem Cell Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, International Stem Cell's adjusted Book Value per Share data for the three months ended in Dec. 2024 was:

Adj_Book= Book Value per Share /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-0.492/133.1571*133.1571
=-0.492

Current CPI (Dec. 2024) = 133.1571.

International Stem Cell Quarterly Data

Book Value per Share CPI Adj_Book
201503 -0.048 99.621 -0.064
201506 0.438 100.684 0.579
201509 0.386 100.392 0.512
201512 0.566 99.792 0.755
201603 -4.567 100.470 -6.053
201606 -0.309 101.688 -0.405
201609 0.116 101.861 0.152
201612 0.870 101.863 1.137
201703 0.159 102.862 0.206
201706 0.396 103.349 0.510
201709 -0.046 104.136 -0.059
201712 0.340 104.011 0.435
201803 0.264 105.290 0.334
201806 0.260 106.317 0.326
201809 0.421 106.507 0.526
201812 0.365 105.998 0.459
201903 0.422 107.251 0.524
201906 -0.159 108.070 -0.196
201909 -0.090 108.329 -0.111
201912 -0.384 108.420 -0.472
202003 -0.378 108.902 -0.462
202006 -0.479 108.767 -0.586
202009 -0.515 109.815 -0.624
202012 -0.575 109.897 -0.697
202103 -0.624 111.754 -0.744
202106 -0.539 114.631 -0.626
202109 -0.545 115.734 -0.627
202112 -0.574 117.630 -0.650
202203 -0.564 121.301 -0.619
202206 -0.553 125.017 -0.589
202209 -0.582 125.227 -0.619
202212 -0.565 125.222 -0.601
202303 -0.556 127.348 -0.581
202306 -0.481 128.729 -0.498
202309 -0.483 129.860 -0.495
202312 -0.524 129.419 -0.539
202403 -0.533 131.776 -0.539
202406 -0.502 132.554 -0.504
202409 -0.505 133.029 -0.505
202412 -0.492 133.157 -0.492

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


International Stem Cell  (OTCPK:ISCO) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of International Stem Cell was 5.29. The lowest was 0.20. And the median was 0.85.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


International Stem Cell Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of International Stem Cell's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


International Stem Cell Business Description

Traded in Other Exchanges
N/A
Address
9745 Businesspark Avenue, San Diego, CA, USA, 92131
International Stem Cell Corp is a clinical-stage biotechnology company. It is focused on therapeutic and biomedical product development with multiple long-term therapeutic opportunities. The company develops different cell types from its stem cells that may result in therapeutic products. The clinical applications of the company include neural stem cells for the treatment of Parkinson's disease and other central nervous system disorders; Liver cells, which are used to treat a variety of congenital and acquired liver diseases; and retinal cells and three-dimensional eye structures. It operates in three segments, the therapeutic market, the biomedical market, and the anti-aging market. The Biomedical products business segment accounts for the majority of revenue.
Executives
Paul V Maier director 3595 JOHN HOPKINS COURT, SAN DIEGO CA 92121
Andrei Semechkin 10 percent owner 1 OVERLOOK DR. UNIT 11, AMHERST NH 03031
Sofya Bakalova officer: Dir. of Legal Affairs & Oper. 5950 PRIESTLY DRIVE, CARLSBAD CA 92008
Wright Don director 2829 RUCKER AVE, 3RD FLOOR, EVERETT WA 98201
Jennifer Stephens officer: Acting Chief Financial Officer 5950 PRIESTLY DRIVE, CARLSBAD CA 92008
Mahnaz Ebrahimi officer: Chief Financial Officer 5950 PRIESTLY DRIVE, CARLSBAD CA 92008
Rouslan Semechkin director, 10 percent owner 2595 JASON CT, OCEANSIDE CA 92056
Tibor Jay Novak officer: Interim CFO 5950 PRIESTLY DRIVE, CARLSBAD CA 92008
John Simon Craw officer: Executive Vice President 5950 PRIESTLY DRIVE, CARLSBAD CA 92008
James H Berglund director C/O INTERNATIONAL STEM CELL CORPORATION, 5950 PRIESTLY DRIVE, CARLSBAD CA 92008
Ar Partners Llc 10 percent owner 5950 PRIESTLY DR., CARLSBAD CA 92008
Kurt Andrew May officer: President and COO 5950 PRIESTLY DRIVE, CARLSBAD CA 92008
Linh T Nguyen officer: Chief Financial Officer 5950 PRIESTLY DR., CARLSBAD CA 92008
Jeffrey Janus director, officer: President 2595 JASON COURT, OCEANSIDE CA 92056
Charles J Casamento director 99 BELBROOK WAY, ATHERTON CA 94027

International Stem Cell Headlines